Alpha -Tocopherol Acetate D- Ascorbic Acid Choleca

證據等級: L5

預測適應症: 0 個

Multi-Vitamin/Mineral Complex (Prenatal Supplement): Insufficient Data for Repurposing Analysis

One-Sentence Summary

This entry represents a multi-component nutritional supplement containing 15 active ingredients — including omega-3 fatty acids (DHA/EPA), multiple B-vitamins, folate forms, Vitamin C/D/E, and essential minerals — consistent with a prenatal or comprehensive nutritional formula. The TxGNN model was unable to generate repurposing predictions for this entry, as the multi-component INN string could not be resolved to a single DrugBank entity. No clinical trial or publication evidence is linked to this candidate in the current dataset.

Quick Overview

Item	Content
Original Indication	Not available (no regulatory record found)
Predicted New Indication	No predictions generated
TxGNN Prediction Score	N/A
Evidence Level	L5 — Model prediction only; no actual predictions generated
US Market Status	Not Marketed (no approvals on record)
Number of NDAs	0
Recommended Decision	Hold

Why No Prediction Was Generated

This candidate was submitted as a single INN string containing 15 co-listed active ingredients:

#	Ingredient	Category
1	D-Alpha-Tocopherol Acetate	Vitamin E
2	Ascorbic Acid	Vitamin C
3	Cholecalciferol	Vitamin D3
4	Cyanocobalamin	Vitamin B12
5	Doconexent (DHA)	Omega-3 fatty acid
6	Folic Acid	B9 (inactive form)
7	Icosapent (EPA)	Omega-3 fatty acid
8	Iron Pentacarbonyl	Mineral — Iron
9	Levomefolate Magnesium	B9 (active form)
10	Magnesium Oxide	Mineral — Magnesium
11	Niacin	Vitamin B3
12	Potassium Iodide	Mineral — Iodine
13	Pyridoxine Hydrochloride	Vitamin B6
14	Riboflavin	Vitamin B2
15	Thiamine	Vitamin B1

The TxGNN knowledge graph operates at the single-entity level: each prediction requires one DrugBank ID mapped to one drug node. Because no DrugBank ID could be resolved from this compound INN string, the pipeline had no graph node to anchor a repurposing traversal, resulting in zero predictions.

This profile is consistent with a prenatal multivitamin formulation (note: dual folate forms — folic acid + levomefolate; DHA/EPA for fetal neurodevelopment; iodine for thyroid function during pregnancy). Such combination products are typically regulated as nutritional supplements rather than prescription drugs, which also explains the absence of NDA records.

Safety Considerations

No safety data is available for this candidate at the combination-product level. For individual ingredient safety, please refer to the respective package inserts or DrugBank entries for each component.

Conclusion and Next Steps

Decision: Hold

Rationale: The pipeline failed at the entity-resolution step — the multi-component INN string could not be linked to a DrugBank node, making TxGNN prediction structurally impossible for this entry as submitted. There is nothing clinically actionable to evaluate.

To proceed, the following is needed:

Decompose the submission: Split the 15 co-listed ingredients into individual INN entries and re-run each through the pipeline separately (e.g., Doconexent, Icosapent, Folic Acid each as standalone candidates).
Identify the intended product: Confirm whether this is a specific branded prenatal product and look up its NDA/ANDA directly (e.g., FDA Orange Book search for prenatal vitamins with DHA).
Correct the candidate ID: The candidate_id is listed as TW-UNKNOWN-multi, suggesting a data ingestion anomaly — investigate upstream data source for parsing errors on multi-component INN fields.
Evaluate individually high-interest components: Doconexent (DHA) and Icosapent (EPA) both have independent TxGNN-eligible DrugBank IDs and active repurposing research (e.g., cardiovascular, neurological indications); these warrant separate evaluation.
Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.